Research Analysts’ Updated EPS Estimates for December, 11th (ABEO, ADBE, AMBA, AVGO, AVID, B4B3, BBCP, BBD, BMCH, BTAI)

Research Analysts’ updated eps estimates for Wednesday, December 11th:

Abeona Therapeutics (NASDAQ:ABEO) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $15.00 price target on the stock.

Adobe (NASDAQ:ADBE) had its buy rating reissued by analysts at Cowen Inc. The firm currently has a $305.00 target price on the stock.

Ambarella (NASDAQ:AMBA) had its buy rating reissued by analysts at Morgan Stanley. Morgan Stanley currently has a $61.00 target price on the stock.

Broadcom (NASDAQ:AVGO) had its buy rating reiterated by analysts at Susquehanna Bancshares Inc. The firm currently has a $345.00 price target on the stock.

Avid Technology (NASDAQ:AVID) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Avid Technology, Inc. develops, markets, sells and supports a wide range of software and systems for creating and manipulating digital media content. Digital media are media elements, whether video or audio or graphics, in which the image, sound or picture is recorded and stored as digital values, as opposed to analog signals. The company’s systems are designed to improve the productivity of video and film editors by enabling them to edit moving pictures and sound in a faster, easier, and more cost-effective manner than traditional analog tape-based systems. “

Metro (ETR:B4B3) was given a €14.70 ($17.09) price target by analysts at Jefferies Financial Group Inc. The firm currently has a neutral rating on the stock.

Concrete Pumping (NASDAQ:BBCP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Concrete Pumping Holdings Inc. provides concrete pumping services and concrete waste management services primarily in U.S. and U.K. Concrete Pumping Holdings Inc., formerly known as Industrea Acquisition Corp., is based in New York, United States. “

Banco Bradesco (NYSE:BBD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Banco Bradesco’s main activities are the provision of banking and insurance services such as private and industrial credit loans, credit cards, mortgaged loans, 24 hour banking, health and life insurance, leasing, pension fund management and services for stock market investors. “

BMC Stock (NASDAQ:BMCH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $33.00 price target on the stock. According to Zacks, “BMC Stock Holdings Inc provides diversified building products and services to professional builders and contractors primarily in the residential housing market. The Company’s portfolio of products and services spans building materials includes millwork and structural component manufacturing capabilities, consultative showrooms and design centers, value-added installation management and eBusiness platform. BMC Stock Holdings, Inc., formerly known as Stock Building Supply Holdings, is headquartered in Raleigh, North Carolina. “

BioXcel Therapeutics (NASDAQ:BTAI) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 price target on the stock.

Evolution Mining (OTCMKTS:CAHPF) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating.

Chewy (NYSE:CHWY) had its buy rating reissued by analysts at William Blair.

Correvio Pharma (NASDAQ:CORV) was downgraded by analysts at Mackie to a hold rating. Mackie currently has $1.60 target price on the stock.

CELYAD SA/ADR (NASDAQ:CYAD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $43.00 price target on the stock.

Fortive (NYSE:FTV) had its hold rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $77.00 price target on the stock.

General Electric (NYSE:GE) was upgraded by analysts at UBS Group AG from a neutral rating to a buy rating. They currently have $14.00 target price on the stock.

Genmab A/S (NASDAQ:GMAB) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $25.00 target price on the stock.

GameStop (NYSE:GME) had its sell rating reissued by analysts at Benchmark Co..

Iluka Resources (OTCMKTS:ILKAF) was downgraded by analysts at Morgan Stanley to a hold rating.

ILUKA RESOURCES/ADR (OTCMKTS:ILKAY) was downgraded by analysts at Citigroup Inc from a neutral rating to a sell rating.

ILUKA RESOURCES/ADR (OTCMKTS:ILKAY) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating.

Mcdonald’s (NYSE:MCD) had its buy rating reissued by analysts at Stephens. Stephens currently has a $225.00 price target on the stock.

Marvell Technology Group (NASDAQ:MRVL) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $32.00 target price on the stock.

Nestlé (VTX:NESN) was given a CHF 118 target price by analysts at Jefferies Financial Group Inc. The firm currently has a buy rating on the stock.

Nuance Communications (NASDAQ:NUAN) had its buy rating reiterated by analysts at Oppenheimer Holdings Inc.. Oppenheimer Holdings Inc. currently has a $23.00 target price on the stock.

Sangamo Therapeutics (NASDAQ:SGMO) had its hold rating reiterated by analysts at Wedbush. Wedbush currently has a $11.00 price target on the stock.

Sol Gel Technologies (NASDAQ:SLGL) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $23.00 target price on the stock.

Spero Therapeutics (NASDAQ:SPRO) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $35.00 price target on the stock.

Shotspotter (NASDAQ:SSTI) had its buy rating reissued by analysts at B. Riley. They currently have a $50.00 target price on the stock.

Stemline Therapeutics (NASDAQ:STML) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $35.00 price target on the stock.

Synlogic (NASDAQ:SYBX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $13.00 target price on the stock.

TiVo (NASDAQ:TIVO) had its buy rating reaffirmed by analysts at B. Riley. B. Riley currently has a $19.00 target price on the stock.

Uranium Energy (NYSEAMERICAN:UEC) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $3.50 price target on the stock.

Exicure (OTCMKTS:XCUR) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 target price on the stock.

Receive News & Ratings for Abeona Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abeona Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.